Author

L. Bellanger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein design· 1

Frequent Co-Authors

F. Gallais· 3 shared S. Debroas· 3 shared D. Gouveia· 2 shared G. Miotello· 2 shared J. Armengaud· 2 shared J.-C. Gaillard· 2 shared L. Grenga· 2 shared O. Pible· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

F. Gallais

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Deep Mutational Engineering of broadly-neutralizing and picomolar affinity nanobodies to accommodate SARS-CoV-1 & 2 antigenic polymorphism

A. Laroche, M. L. Orsini Delgado, P. Cuniasse, S. Dubois, R. Sierocki, F. Gallais, S. Debroas, L. Bellanger, S. Simon, B. Maillere, H. Nozach

This study engineers nanobodies with picomolar affinity and broad neutralizing activity against SARS-CoV-1 and SARS-CoV-2 variants using Deep Mutational Engineering.

bioRxiv · Dec 7, 2021 · PreprintBiochemistry

Proteotyping SARS-CoV-2 virus from nasopharyngeal swabs: a proof-of-concept focused on a 3 min mass spectrometry window

D. Gouveia, G. Miotello, F. Gallais, J.-C. Gaillard, S. Debroas, L. Bellanger, J.-P. Lavigne, A. Sotto, L. Grenga, O. Pible, J. Armengaud

This paper demonstrates the use of mass spectrometry to detect SARS-CoV-2 peptides in nasopharyngeal swabs, showing potential for rapid and specific viral diagnosis.

bioRxiv · Jun 19, 2020Microbiology

Shotgun proteomics of SARS-CoV-2 infected cells and its application to the optimisation of whole viral particle antigen production for vaccines

L. Grenga, F. Gallais, O. Pible, J.-C. Gaillard, D. Gouveia, H. Batina, N. Bazaline, S. Ruat, K. Culotta, G. Miotello, S. Debroas, M.-A. Roncato, G. Steinmetz, C. Foissard, A. Desplan, , J. Armengaud

This study uses shotgun proteomics to optimize viral particle antigen production for vaccines and analyze host cell proteome changes during SARS-CoV-2 infection.

bioRxiv · Apr 17, 2020Microbiology